Lansoprazole Capsule, Delayed Release
Product Images NDC 82009-039

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 82009-039). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazolefigure1 (Lansoprazolefigure1)

A line graph titled 'Mean Severity of Day Heartburn By Study Day For Evaluable Patients' showing mean severity scores from 0 to 3 over approximately 60 days from start of treatment. The graph compares placebo, Lansoprazole 15 mg once daily, and Lansoprazole 30 mg once daily groups, with severity decreasing over time for the Lansoprazole groups more than placebo.*

FDA Label Image

Lansoprazolefigure2 (Lansoprazolefigure2)

A line graph showing the mean severity of night heartburn in evaluable patients over 60 days of treatment. The graph compares three groups: placebo, lansoprazole 15 mg once daily, and lansoprazole 30 mg once daily, with severity scores decreasing over time for both lansoprazole doses more than placebo.*

FDA Label Image

Lansoprazolestructure (Lansoprazolestructure)

Chemical structure of lansoprazole, an oral delayed-release capsule ingredient. The structure includes a benzimidazole ring connected to a sulfinyl group and a pyridine ring with trifluoromethyl substitution.*

FDA Label Image

Lansoprazole-30mg-500s-count-container-label (Lansoprazole 30mg 500s Count Container Label)

This packaging label is for Lansoprazole Delayed-Release Capsules, USP 30 mg, manufactured for Quallent Pharmaceuticals Health LLC. It includes storage instructions, a barcode, and states the bottle contains 500 capsules. The label also advises dispensing a Medication Guide and lists the manufacturer location in the Cayman Islands and Hetero Labs Limited in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.